How doctors think about medical cannabis for pain

2 mins read

Since 2018, Business of Cannabis has produced Medical Cannabis Week to surface and celebrate insights and innovations from patients, practitioners and the industry. While a full week, in-person Medical Cannabis Week event was not possible in May 2020, we moved ahead with a weeklong, virtual Medical Cannabis Week in November 2020.

Since joining Canopy Growth in July 2018, Dr. Mark Ware has helped establish the Company’s global medical division, Spectrum Therapeutics and led the team responsible for supply and regulatory documentation, clinical development, medical affairs and global product safety.He began evaluating the role of cannabis in pain management at McGill University in 1999, where he served as Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre for over 10 years.

Dr. Ware was cofounder of the non-profit Canadian Consortium for the Investigation of Cannabinoids and served as Executive Director from 2007 to 2018. He has advised the Canadian federal government on cannabis policy since 2001, and 2016, he served as the vice chair of the Federal Task Force on the Legalization and Regulation of Cannabis in Canada.

Dr. Ware has over 100 publications on cannabis and pain in peer-reviewed journals and has spoken widely and national and international conferences on cannabis in medicine.

Dr. Ware joined Medical Cannabis Week 2020 to talk about his background in medical cannabis as well as how more doctors are incorporating medical cannabis for patients with chronic pain.


Previous Story

How educating doctors about medical cannabis benefits patients

Next Story

Medical Cannabis Week | Tuesday, November 17

0 £0.00